F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, staff interview, physician interview, and review of medication information from
Medscape, the facility failed to administer seizure medications for a resident who was admitted to the facility
from the hospital with a new onset of seizure disorder resulting in significant medication errors. This
affected one (Resident #30) of three residents reviewed for medication administration. The facility census
was 29.
Residents Affected - Few
Findings include:
Review of the medical record of Resident #30 revealed an admission date of 09/12/24, a transfer to the
hospital on [DATE] and then discharged home on [DATE], with a return to the facility on [DATE] after
retruning to the hosptial on 09/29/2024. Diagnoses included unspecified convulsions, Parkinson's disease
with dyskinesia without mention of fluctuations, repeated falls, wedge compression fracture of T5-T6
vertebra (on admission), and type II diabetes mellitus.
Review of the admission Minimum Data Set assessment dated [DATE] revealed Resident #30 was
cognitively intact and required supervision assistance for toileting, bathing, and dressing.
Review of the progress note dated 09/25/24 at 8:21 A.M. LPN #100 documented Resident #30 was
nonresponsive and shaking all over with seizure-like activity. Resident #30 was sent to the emergency
room.
Further review of the medical record revealed Resident #30 returned to the facility from the hospital on
[DATE] at approximately 4:15 P.M. with a new diagnosis of new onset seizures. Review of the hospital
discharge paperwork dated 10/10/24 revealed new orders for Keppra (anticonvulsant medication) 1000
milligrams by mouth twice daily for convulsions and Vimpat (anticonvulsant medication) 100 mg by mouth
twice daily for convulsions.
Review of the document titled, Electronically Transmitted Prescription, dated 10/10/24 at 8:19 P.M. revealed
the pharmacy was advised of the admission medications for Resident #30. The form did not indicate if the
medications were ordered as stat.
Review of the Medication Administration Record (MAR) revealed the Keppra and Vimpat were not
administered on 10/10/24.
Further review of the medical record revealed no documentation the physician was notified Keppra and
Vimpat were not administered.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
366468
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366468
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/31/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Vancrest of Payne
650 North Main Street
Payne, OH 45880
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the progress note dated 10/10/24 at 11:23 P.M. documented by Licensed Practical Nurse (LPN)
#106, revealed Resident #30 was alert and oriented to person, place, time, and event, pleasant and
cooperative. Her speech was clear. Focal seizure-like activity had been noted during supper lasting 10
minutes. Seizure precautions were in place and Resident #30 had been able to answer questions during
the active episode. Blood pressure, heart rate, and respiratory rate were within normal limits. Resident #30
remained continent of bowel and bladder with minimal intermittent urinary incontinence. The documentation
is absent of any family or physician notification.
Review of the progress note dated 10/11/24 at 9:01 A.M. documented by Registered Nurse (RN) #128,
revealed the nurse was alerted to Resident #30's room by son-in-law. Upon entry to the room, RN #128
noted Resident #30 lying in bed, her body was shaking, her eyes were fixed open and pupils dilated.
Resident #30 was not responsive to verbal or tactile stimuli. Resident #30's respirations varied but the
partial oxygen saturation remained between 89 to 97% (percent) on room air. The episode occurred for an
extended period with the convulsions slowly subsiding. The Director of Nursing (DON) arrived at the room
and the son-in-law refused to have Resident #30 transported to the emergency room stating ,what good
would it do? She will end back up in a larger hospital and she does not want to be there. The DON notified
the physician of the interaction. Review of the progress note at 9:45 A.M., documented by RN #166,
revealed a late entry: received orders from Nurse Practitioner to administer two mg of Ativan twice to help
control the seizures and a one time dose to administer Keppra 1000 mg liquid orally. A progress note, on
10/11/24 at 4:21 P.M. documented by RN #128 revealed an order to begin Diastat (anticonvulsant) rectally
as needed.
Review of the MAR revealed Levetiracetam (Keppra) 100 mg per milliliters (ml), 10 ml was administered
10/11/24 at 9:34 A.M.
Review of the pharmacy, Delivery Sheet, dated 10/11/24 and time stamped 12:22 P.M. revealed six tablets
of Keppra 1000 mg was delivered, along with 11 other medications for Resident #30.
Interview on 10/22/24 at 8:40 A.M. with the Director of Nursing (DON) revealed Resident #30 arrived at the
facility on 10/10/24 at a little after 4:00 P.M. without the transferring hospital having given any report. The
facility did not have some of her medications.
Interview on 10/22/24 at 3:00 P.M. with Pharmacist #500 revealed medications were delivered on 10/11/24
between 1:00 P.M. and 1:30 P.M. which included Keppra 1000 mg six tablets, among others.
Interview on 10/31/24 at 9:34 A.M. with LPN #101 revealed she had been on duty when Resident #30
arrived back to the facility from the hospital on [DATE]. LPN #101 stated she had put the medication orders
into the computer. She stated she normally will also print out a copy of the orders and fax them to the
pharmacy but could not be certain she had done that. The facility does not keep a record of fax
transactions.
Telephone interview on 10/31/24 at 9:39 A.M. with Certified Nurse Practitioner (CNP) #500 revealed she
had not been contacted related to the unavailability of the Keppra and Vimpat. CNP #500 stated if she
would have been notified, she would have called the pharmacy herself or called a local pharmacy to have
an emergency supply drop shipped and also given an order for an as needed medication the facility does
have in the emergency box. She further reported having been called on 10/11/24 of the active seizure
occurring and had given the Ativan order and added the Diastat order. CNP #500 stated she had attempted
to have Resident #30 returned to the hospital numerous times and the family refused.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366468
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366468
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/31/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Vancrest of Payne
650 North Main Street
Payne, OH 45880
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Interview on 10/31/24 at 10:30 A.M. with the DON revealed the Keppra liquid was borrowed from another
resident.
Telephone interview on 10/31/24 at 11:02 A.M. with RN #128 revealed she guessed Resident #30's seizure
began on 10/11/24 a little after 8:00 A.M. RN #128 stated she remained with Resident #30 for the duration
and had sent a State Tested Nursing Assistant (STNA) to get another nurse. RN #128 stated the DON
came and assisted and got the order for the Ativan.
Interview on 10/31/24 at 11:54 A.M. with the DON revealed there was no documentation in the medical
record indicating the physician was made aware of Keppra and Vimpat not being available for Resident #30.
The DON further verified the medications were not administered timely.
Review of medication information from Medscape at
https://reference.medscape.com/drug/keppra-spritam-levetiracetam-343013#91 revealed Vimpat and
Keppra are used for seizure disorder. Further review revealed, Do not stop taking this medication without
consulting your doctor. Your seizures may become worse when the drug is suddenly stopped.
This deficiency represents non-compliance investigated under Complaint Number OH00159061.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366468
If continuation sheet
Page 3 of 3